ReviewFrontiers in oncology2022

Overcoming resistance to immune checkpoint inhibitors in hepatocellular carcinoma: Challenges and opportunities.

Qingqing Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.